Meso Scale Discovery LLC (AKA: MSD~Meso Scale Diagnostics LLC) Profile last edited on: 11/2/2020
CAGE: 1ZHK4
UEI: MBWYUNWCFJ58
Business Identifier: Multiplex biological assays 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
1601 Research Boulevard
Rockville, MD 20850
Rockville, MD 20850
| (240) 314-2600 |
| customerservice@mesoscale.com |
| www.mesoscale.com |
Location: Single
Congr. District: 08
County: Montgomery
Congr. District: 08
County: Montgomery
Public Profile
Meso Scale Discovery, a division of Meso Scale Diagnostics, LLC ("MSD") develops and markets solutions for multiplex biological assays including assays for biomarkers, cytokines, and phosphoproteins. MSD's platform is based on MULTI-ARRAY technology, a proprietary combination of patterned arrays and electrochemiluminescence detection, enabling large numbers of measurements with exceptional sensitivity, wide dynamic range and convenience. Meso Scale Discovery provides biomedical assays and kits for cytokines and chemokines, cell signaling pathways, cardiac, toxicology, metabolic, vascular and growth factors, fertility, alzheimers disease, hypoxia and bone
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
150-249Revenue Range
15M-20MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2014 | 1 | NIH | $297,840 | |
| Project Title: Recombinant Antibodies for Antibody Arrays | ||||
| 2013 | 1 | NIH | $149,064 | |
| Project Title: Portable MULTI-ARRAY Test for Recent HIV Infection | ||||
| 2013 | 1 | NIH | $224,847 | |
| Project Title: Integrated Multiplex Diagnostic Platforms for Infectious Diseases | ||||
| 2013 | 2 | NIH | $470,358 | |
| Project Title: Multiplex Serology for Encephalitis | ||||
| 2013 | 2 | NIH | $584,662 | |
| Project Title: Non-Radioactive Multiplexed Assays for Prediction/Diagnosis of T1d and Comorbid A | ||||
Key People / Management
Jacob Wohlstadter -- President
Ilia Davydov
Jeff D Debad
Radoslav Goldman
John H Kenten
Anu Mathew
Martin Stengelin
Ilia Davydov
Jeff D Debad
Radoslav Goldman
John H Kenten
Anu Mathew
Martin Stengelin
